PPHM Stock | News | Quote | Stock Forum | Sunday, October 6,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Peregrine Pharmaceuticals, Inc. PPHM Company Overview 

Stock Message Board http://investorshangout.com/search?q=PPHM&...mp;yt1=Go!

Last Updated: Sunday, October 6, 2013 6:45:23 PM

Peregrine Pharmaceuticals, Inc. PPHM Current Price and Quotes
Last Price 1.48
Previous Close 1.47 Open 1.47
Daily Range 1.49 - 1.46 52wk Range 2.78 - 0.67
Volume 1,459,449 Dividend N/A
Average Vol (3m) 1,162,811 Yield N/A
Peregrine Pharmaceuticals, Inc. PPHM
Company Information

14272 Franklin Avenue
Tustin, CA 92780

Website: http://www.techniclone.com
Phone: (714) 508-6000

Peregrine Pharmaceuticals, Inc. PPHM
Not Available

Peregrine Pharmaceuticals, Inc. PPHM
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Jul 31, 2013 10-Q
CIK 0000704562
Fiscal Year End 4/30
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes

Formerly=Techniclone Corp. until 11-00
Note=3-97 State of incorporation California changed to Delaware
Formerly=Techniclone International Corp. until 9-96
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Peregrine Pharmaceuticals, Inc. PPHM
PPHM Security Details

Share Structure

Market Value1 $231,562,449 a/o Oct 04, 2013
Shares Outstanding 156,461,114 a/o Sep 05, 2013
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Security Notes

New & Secondary Issue=12-82 150,000,000 shs in units (1 sh Com & 0.2 Warr 3-17-85) at 1 cent per unit (best efforts-60,000,000 units min.) by Brooks, Hamburger, Satnick, Inc.
Capital Change=shs decreased by 1 for 5 split. Pay date=10/19/2009.
Short Selling Data

Short Interest 1,946,062 (8.29%)
Nov 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

Executive Registrar & Transfer Agent, Inc.

Peregrine Pharmaceuticals, Inc. PPHM Recent News

Sept 17, 2013 Record Use of At-the-Market (ATM) Offerings by U.S. Life Sciences Companies in First Half of 2013, Reports Brinson Patrick
Sept 10, 2013 Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2014 Financial Results and Recent Developments
Sept 9, 2013 Data Supporting Bavituximab's Immunotherapy Mechanism of Action Published in the Peer-Reviewed AACR Journal Cancer Immunology Research
Sept 7, 2013 Early Briefing and Review: Celgene Corp., Edwards Lifesciences Corp., Forest Laboratories Inc., and Peregrine Pharma Inc.
Sept 4, 2013 Peregrine to Report First Quarter Fiscal Year 2014 Financial Results After Market Close on September 9, 2013
Aug 14, 2013 Bavituximab's Mechanism of Action Highlighted at Immunomodulatory Therapeutic Antibodies for Cancer Conference
Aug 7, 2013 Peregrine Pharmaceuticals to Present at Upcoming Conferences
Jul 31, 2013 Morning Research: Celgene, Edwards Lifesciences, Forest Laboratories, and Peregrine Pharma
Jul 12, 2013 Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2013 Financial Results and Recent Developments


Peregrine Pharmaceuticals, Inc. PPHM Financials
Period Ending Apr 30, 2013 Apr 30, 2012 Apr 30, 2011 Apr 30, 2010
Total Revenue 21,683 15,233 13,492 27,943
Cost of Revenue 12,595 10,153 7,296 8,716
Gross Profit 9,088 5,080 6,196 19,227
Operating Expenses

Research and Development 24,306 35,688 29,462 24,658
Sales, General and Admin. 13,134 11,462 11,421 8,182
Non-Recurring Items - - - -
Other - - - -
Operating Income (28,352) (42,070) (34,687) (13,613)
Income From Continuing Operations

Add'l Income/Expense Items (1,374) 41 1,052 116
Earnings Before Interest and Tax (28,030) (42,029) (33,635) (13,497)
Interest Expense 54 90 516 997
Earnings Before Tax (28,084) (42,119) (34,151) (14,494)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (29,780) (42,119) (34,151) (14,494)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (29,780) (42,119) (34,151) (14,494)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (29,780) (42,119) (34,151) (14,494)

PPHM Peregrine Pharmaceuticals, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PPHM&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PPHM/quote
Stock Chart http://www.otcmarkets.com/stock/PPHM/chart
Company Info http://www.otcmarkets.com/stock/PPHM/company-info
Recent News http://www.otcmarkets.com/stock/PPHM/news
Financials http://www.otcmarkets.com/stock/PPHM/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PPHM/filings
Short Sales http://www.otcmarkets.com/stock/PPHM/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PPHM/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PPHM/research
Summary http://finance.yahoo.com/q?s=PPHM
Historical Prices http://finance.yahoo.com/q/hp?s=PPHM+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PPHM
Basic Chart http://finance.yahoo.com/q/bc?s=PPHM+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PPHM+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PPHM+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PPHM+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PPHM+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PPHM+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PPHM+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PPHM+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PPHM+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PPHM+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PPHM
Balance Sheet http://finance.yahoo.com/q/bs?s=PPHM
Cash Flow http://finance.yahoo.com/q/cf?s=PPHM+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PPHM
Market Watch http://www.marketwatch.com/investing/stock/PPHM
Bloomberg http://www.bloomberg.com/quote/PPHM:US
Morningstar http://quotes.morningstar.com/stock/s?t=PPHM
Bussinessweek http://investing.businessweek.com/research/st...icker=PPHM
Barchart http://www.barchart.com/quotes/stocks/PPHM
OTC Short Report http://otcshortreport.com/index.php?index=PPHM
Investopedia http://www.investopedia.com/markets/stocks/PPHM/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 509

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 0

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 523

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 441

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Thames Ventures VCT 1 PLC Reports Unaudited NAV for 2024

Updated Category News Views 81

Thames Ventures VCT 1 PLC Releases Unaudited NAV for 2024 Thames Ventures VCT 1 PLC has provided important updates about its financial status through its unaudited net asset value (NAV). As of June 30, 2024, the NAV stands at 45.9p per share. This announcement is significant for both the company and its investors, as understanding the NAV is essential for evaluating the...

Continue Reading
Gap Inc Achieves Impressive Growth and Market Expansion

Updated Category News Views 362

Gap Inc Reports Promising Financial Results Shares of Gap Inc (GAP) saw a significant uptick in early trading on Friday following the announcement of their latest quarterly results. This positive financial report highlighted a stronger performance than expected, showcasing the company's effective strategies and management efforts. Analysts' Positive Outlook on Gap In the...

Continue Reading
The Town Lake Company's Bold New Industrial Project Launch

Updated Category News Views 226

The Town Lake Company Initiates New Industrial Development Benchmark Business Parks, a division of The Town Lake Company, has proudly initiated construction on its latest small-bay industrial project. This significant development is located at 1433 Chris Lane and will encompass an impressive 84,200 square feet of innovative tilt-wall flex industrial space. The project is...

Continue Reading
Investors Unite in Class Action Against Everus Construction Group

Updated Category News Views 330

Opportunity for Investors in Everus Construction Group, Inc. In recent developments, investors of Everus Construction Group, Inc. (NYSE: ECG) have found themselves in the midst of a class action lawsuit that has drawn considerable attention. This lawsuit targets purchases made by investors during a specified period, raising important questions about the company's...

Continue Reading
Lam Research Board Approves Quarterly Dividend Announcement

Updated Category News Views 120

Lam Research Corporation Declares New Dividend Lam Research Corporation (Nasdaq: LRCX) has recently made an important announcement regarding its financial strategy. In their latest meeting, the company's Board of Directors approved a quarterly dividend of $0.23 per share for all common stockholders. This decision reflects Lam Research's commitment to providing value to...

Continue Reading